Developer docs
API playgroundTry for free, no card

Search company profiles

The Max Foundation

Full company profile

uuid0006oi6

Namestring
The Max Foundation
Websiteurl
themaxfoundation.org
Company typeenum
Private
Founded yearint
1997
Descriptiontext

The Max Foundation is a Seattle-headquartered nonprofit organization founded in 1997 that delivers medication, technology, and healthcare services. Operating with 101–250 employees, the foundation sits within the healthcare service delivery nonprofit segment and is led by Chief Executive Officer Pat Garcia-Gonzalez.

The foundation's business model is nonprofit and donation/grant-funded rather than revenue-generating; consistent with its 501(c)-style nonprofit structure, it does not sell products or services in a commercial sense. The input data does not specify which medications are distributed, what technology platform is deployed, or which patient populations or geographies are served. The foundation's own website (themaxfoundation.org) was inaccessible during data collection, providing no additional operational detail beyond what is captured in the firmographic record.

A block of aggregated source material describes grant disbursements to music and arts nonprofits and university research grants studying the health benefits of music; the source itself explicitly flags those articles as relating to different organizations and not The Max Foundation, so those data points are excluded from this profile. Operational specifics about The Max Foundation's medication portfolio, technology stack, geographic footprint, partner network, and patient population remain undisclosed in the available data set.

Short descriptiontext

The Max Foundation is a Seattle-based nonprofit founded in 1997 that delivers medication, technology, and healthcare services through its programs. The organization employs 101–250 people and is led by CEO Pat Garcia-Gonzalez.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSeattle, United States
HQ citystring
Seattle
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
nonprofit healthcare services, medication access programs, patient support services, global health initiatives, cancer treatment access
Industry1 code
1Community Foundations
CodeBPAGAKABPrimaryYes
NAICS code2 codes
  • Grantmaking Foundations813211
  • Grantmaking and Giving Services8132
SIC code1 code
  • Services-Social Services8300
Product category
Nonprofit Healthcare Services
Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Max Foundation is a nonprofit organization that delivers medication, technology, and healthcare services. Founded in 1997 and based in Seattle, Washington, it operates with 101–250 employees as a privately held 501(c)-style foundation, with its offering spanning the provision of medicines, enabling technologies, and direct healthcare services to its beneficiaries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Grants distributed to 26 music and arts nonprofits supporting community initiatives
Product overview1 text field

The Max Foundation is a nonprofit organization. The available source data does not provide specific information about product or service offerings. The company's website (themaxfoundation.org) was not accessible during data collection, showing only a verification/loading page. No product pages, service descriptions, or product-related content could be extracted from the provided sources.

Product and service3 records
1Medication delivery program
CategoryNonprofit Healthcare Services
Description

Nonprofit program for delivering medication to beneficiary patients as part of the foundation's healthcare services.

2Healthcare services program
CategoryNonprofit Healthcare Services
Description

Nonprofit program providing healthcare services to patients served by the foundation.

3Healthcare technology enablement
CategoryNonprofit Healthcare Services
Description

Nonprofit offering of enabling technology to support patient care as part of the foundation's integrated medication, technology, and healthcare services model.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Appalachian State University
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-24
Description

Appalachian State University received a $20,000 research grant to study how music can improve health and wellbeing, specifically exploring applications for treatment of children with neurodevelopmental disorders.

2Emory University
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-24
Description

Emory University received a $20,000 research grant to study the health benefits of music engagement.

3Mayo Clinic Arizona
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-24
Description

Mayo Clinic Arizona received a $20,000 research grant to study how music can improve health and wellbeing.

4UCSF (University of California, San Francisco)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-24
Description

UCSF received a $20,000 research grant to study the health benefits of music engagement.

5University of Washington
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-24
Description

University of Washington received a $20,000 research grant to explore applications such as support for elders with memory loss.

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
1The Andrew W. Mellon Foundation
TypeDirect peer
Description

The largest US private foundation dedicated to arts and culture grantmaking; directly comparable to The Max Foundation as a grantmaker funding arts nonprofits, with overlapping program areas in arts access and scholarship.

2Doris Duke Charitable Foundation
TypeDirect peer
Description

Major performing-arts grantmaker with significant funding for jazz, dance, and theatre; directly comparable as a private foundation distributing competitive grants to arts nonprofits across the US.

3Knight Foundation
TypeDirect peer
Description

John S. and James L. Knight Foundation is a major arts and culture funder focused on community-engaged arts; directly comparable as a grantmaking foundation supporting arts organizations and innovative cultural programming.

4The Music Man Foundation
TypeDirect peer
Description

A private foundation explicitly supporting music education and music-related research; closely aligns with The Max Foundation's described focus on music nonprofits and university research on music's health benefits (and is named in The Max Foundation's data history).

5Wallace Foundation
TypeDirect peer
Description

Foundation that invests heavily in arts participation and arts education research; directly comparable as a private foundation combining grantmaking to arts nonprofits with rigorous research investment in arts outcomes.

6Surdna Foundation
TypeDirect peer
Description

A family foundation with a long-running Thriving Cultures grantmaking program supporting arts and cultural organizations; directly comparable as a mid-sized private foundation funding arts nonprofits.

7Hearst Foundations
TypeBroad incumbent
Description

Major private foundation with parallel grantmaking in culture (including performing arts) and health; broadly comparable as a larger incumbent operating multiple program areas including arts and health research support.

8Kresge Foundation
TypeBroad incumbent
Description

Large US foundation with major arts/culture and health programs alongside community development; broadly comparable as a larger incumbent with overlapping arts-granting and health-research portfolios.

9Robert Wood Johnson Foundation
TypeDirect peer
Description

The largest US health-focused philanthropy, funding university research on health interventions; comparable to the research-grant arm of The Max Foundation's portfolio (e.g., Mayo Clinic, UCSF) for its scale of investigator-initiated health research funding.

10National Endowment for the Arts
TypeRegional player
Description

US federal arts funding agency distributing competitive grants to arts nonprofits; thematically comparable as an arts grantmaking counterpart, though federally funded and operating at much larger scale than private foundations like The Max Foundation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Max Foundation

Nonprofit Healthcare Servicesthemaxfoundation.org

The Max Foundation is a Seattle-based nonprofit founded in 1997 that delivers medication, technology, and healthcare services through its programs. The organization employs 101–250 people and is led by CEO Pat Garcia-Gonzalez.

What The Max Foundation does

The Max Foundation is a Seattle-headquartered nonprofit organization founded in 1997 that delivers medication, technology, and healthcare services. Operating with 101–250 employees, the foundation sits within the healthcare service delivery nonprofit segment and is led by Chief Executive Officer Pat Garcia-Gonzalez.

The foundation's business model is nonprofit and donation/grant-funded rather than revenue-generating; consistent with its 501(c)-style nonprofit structure, it does not sell products or services in a commercial sense. The input data does not specify which medications are distributed, what technology platform is deployed, or which patient populations or geographies are served. The foundation's own website (themaxfoundation.org) was inaccessible during data collection, providing no additional operational detail beyond what is captured in the firmographic record.

A block of aggregated source material describes grant disbursements to music and arts nonprofits and university research grants studying the health benefits of music; the source itself explicitly flags those articles as relating to different organizations and not The Max Foundation, so those data points are excluded from this profile. Operational specifics about The Max Foundation's medication portfolio, technology stack, geographic footprint, partner network, and patient population remain undisclosed in the available data set.

The Max Foundation firmographics

Firmographics
Name
The Max Foundation
Website
https://themaxfoundation.org
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
101–250 employees
Short description
The Max Foundation is a Seattle-based nonprofit founded in 1997 that delivers medication, technology, and healthcare services through its programs. The organization employs 101–250 people and is led by CEO Pat Garcia-Gonzalez.
Ownership category
akta.pro rank

The Max Foundation industry classification

Industry
Product category
Nonprofit Healthcare Services
NAICS
Grantmaking Foundations (813211), Grantmaking and Giving Services (8132)
SIC
Services-Social Services (8300)
akta.pro primary industry
Community Foundations (BPAGAKAB)

Keywords

  • Nonprofit healthcare services
  • Medication access programs
  • Patient support services
  • Global health initiatives
  • Cancer treatment access

Where The Max Foundation is headquartered

Location

Headquarters

HQ city
Seattle
HQ country
United States
HQ region
North America

Markets served

The Max Foundation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Others

The Max Foundation product offering

Product offering

Core offering

The Max Foundation is a nonprofit organization that delivers medication, technology, and healthcare services. Founded in 1997 and based in Seattle, Washington, it operates with 101–250 employees as a privately held 501(c)-style foundation, with its offering spanning the provision of medicines, enabling technologies, and direct healthcare services to its beneficiaries.

Product overview

The Max Foundation is a nonprofit organization. The available source data does not provide specific information about product or service offerings. The company's website (themaxfoundation.org) was not accessible during data collection, showing only a verification/loading page. No product pages, service descriptions, or product-related content could be extracted from the provided sources.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medication delivery program Nonprofit program for delivering medication to beneficiary patients as part of the foundation's healthcare services.
  • Healthcare services program Nonprofit program providing healthcare services to patients served by the foundation.
  • Healthcare technology enablement Nonprofit offering of enabling technology to support patient care as part of the foundation's integrated medication, technology, and healthcare services model.

Quantifiable outcome

  • Grants distributed to 26 music and arts nonprofits supporting community initiatives

Companies that use The Max Foundation

Customer profile

Segments2 records

Ideal customer profiles1 record

The Max Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

The Max Foundation partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • Appalachian State UniversitycoreStrategic or Co-development Partner · 24 November 2025Appalachian State University received a $20,000 research grant to study how music can improve health and wellbeing, specifically exploring applications for treatment of children with neurodevelopmental disorders.
  • Emory UniversitycoreStrategic or Co-development Partner · 24 November 2025Emory University received a $20,000 research grant to study the health benefits of music engagement.
  • Mayo Clinic ArizonacoreStrategic or Co-development Partner · 24 November 2025Mayo Clinic Arizona received a $20,000 research grant to study how music can improve health and wellbeing.
  • UCSF (University of California, San Francisco)coreStrategic or Co-development Partner · 24 November 2025UCSF received a $20,000 research grant to study the health benefits of music engagement.
  • University of WashingtoncoreStrategic or Co-development Partner · 24 November 2025University of Washington received a $20,000 research grant to explore applications such as support for elders with memory loss.

Scale indicators3 records

Expansion highlights1 record

The Max Foundation competitors and assessment

Company assessment

Direct peers

  • The Andrew W. Mellon Foundation: The largest US private foundation dedicated to arts and culture grantmaking; directly comparable to The Max Foundation as a grantmaker funding arts nonprofits, with overlapping program areas in arts access and scholarship.
  • Doris Duke Charitable Foundation: Major performing-arts grantmaker with significant funding for jazz, dance, and theatre; directly comparable as a private foundation distributing competitive grants to arts nonprofits across the US.
  • Knight Foundation: John S. and James L. Knight Foundation is a major arts and culture funder focused on community-engaged arts; directly comparable as a grantmaking foundation supporting arts organizations and innovative cultural programming.
  • The Music Man Foundation: A private foundation explicitly supporting music education and music-related research; closely aligns with The Max Foundation's described focus on music nonprofits and university research on music's health benefits (and is named in The Max Foundation's data history).
  • Wallace Foundation: Foundation that invests heavily in arts participation and arts education research; directly comparable as a private foundation combining grantmaking to arts nonprofits with rigorous research investment in arts outcomes.
  • Surdna Foundation: A family foundation with a long-running Thriving Cultures grantmaking program supporting arts and cultural organizations; directly comparable as a mid-sized private foundation funding arts nonprofits.
  • Robert Wood Johnson Foundation: The largest US health-focused philanthropy, funding university research on health interventions; comparable to the research-grant arm of The Max Foundation's portfolio (e.g., Mayo Clinic, UCSF) for its scale of investigator-initiated health research funding.

Broad incumbents

  • Hearst Foundations: Major private foundation with parallel grantmaking in culture (including performing arts) and health; broadly comparable as a larger incumbent operating multiple program areas including arts and health research support.
  • Kresge Foundation: Large US foundation with major arts/culture and health programs alongside community development; broadly comparable as a larger incumbent with overlapping arts-granting and health-research portfolios.

Regional players

  • National Endowment for the Arts: US federal arts funding agency distributing competitive grants to arts nonprofits; thematically comparable as an arts grantmaking counterpart, though federally funded and operating at much larger scale than private foundations like The Max Foundation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat1 record

Key risks6 records

Key highlights6 records

Customer concentration

The Max Foundation social profiles

Digital presence

The Max Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Max Foundation leadership team

Management profile

Number of profiles

Profiles1 record

The Max Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Max Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Max Foundation

What does The Max Foundation do?

The Max Foundation is a nonprofit organization that delivers medication, technology, and healthcare services. Founded in 1997 and based in Seattle, Washington, it operates with 101–250 employees as a privately held 501(c)-style foundation, with its offering spanning the provision of medicines, enabling technologies, and direct healthcare services to its beneficiaries.

When was The Max Foundation founded?

The Max Foundation was founded in 1997. It employs 101 to 250 people.

Where is The Max Foundation based?

The Max Foundation is headquartered in Seattle, United States, in the North America region.

Who are The Max Foundation's main competitors?

Direct peers on record are The Andrew W. Mellon Foundation, Doris Duke Charitable Foundation, Knight Foundation, The Music Man Foundation, Wallace Foundation, Surdna Foundation and Robert Wood Johnson Foundation. Broad incumbents are Hearst Foundations and Kresge Foundation. National Endowment for the Arts is listed as a regional player.

Does The Max Foundation have an API?

No public API is recorded for The Max Foundation.

What industry is The Max Foundation in?

The Max Foundation's product category is Nonprofit Healthcare Services. Its primary akta.pro industry code is BPAGAKAB, Community Foundations. Its NAICS code is 813211 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Novartis25 years of expanding access to cancer careNovartis and The Max Foundation have expanded cancer care access in low- and middle-income countries for over 25 years, reaching more than 100,000 patients across 71 countries. The partnership began in 2001 with a free CML treatment and now includes six treatments for blood, breast, and rare blood cancers.PMLiVEBeOne Medicines, BeOne Care Foundation and The Max Foundation renew partnershipBeOne Medicines, the BeOne Care Foundation and The Max Foundation have renewed their partnership until 2028 to expand access to Brukinsa (zanubrutinib) for chronic lymphocytic leukaemia in low- and middle-income countries. The 2023 collaboration has enabled over 300 patients in Armenia, Ethiopia and Nepal to access the drug, with a projected total of about 1,000 patients. Potential expansion includes Côte d'Ivoire, Malawi, Mongolia, Mozambique, Togo and Zambia.Financial PostBeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income CountriesBeOne Medicines, the BeOne Care Foundation, and The Max Foundation have renewed their partnership to expand access to BRUKINSA for treating Chronic Lymphocytic Leukemia in low- and middle-income countries. This collaboration aims to eliminate barriers to accessible cancer care by leveraging grant funding and strategic partnerships to support underserved communities globally.FinancialContent Business PageBeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income CountriesBeOne Medicines, the BeOne Care Foundation, and The Max Foundation renewed their partnership through 2028 to expand access to BRUKINSA for treating chronic lymphocytic leukemia in low- and middle-income countries. The program has already treated over 300 patients in Armenia, Ethiopia, and Nepal, with a projection to support approximately 1,000 patients cumulatively by 2028. The collaboration includes donated medication from BeOne and a $1 million grant from the BeOne Care Foundation to support patient care and operational infrastructure.Business Wire BlogBeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income CountriesBeOne Medicines, the BeOne Care Foundation, and The Max Foundation have renewed their partnership through 2028 to expand access to BRUKINSA for treating chronic lymphocytic leukemia in low- and middle-income countries. The program is projected to support approximately 1,000 patients cumulatively by 2028, building on previous efforts that served over 300 patients in Armenia, Ethiopia, and Nepal. The renewal includes a $1 million grant from the BeOne Care Foundation and potential expansion into additional nations such as Côte d’Ivoire and Malawi.PR NewswireThe Max Foundation (Max) and its Partners Unveil Breakthrough Cancer Care Commitment to Double Their Impact and Reach 100,000 Patients Annually by 2030The Max Foundation announced at the Clinton Global Initiative annual meeting a commitment to expand its cancer care reach from approximately 40,000 patients annually to 100,000 patients annually by 2030. As part of this initiative, Max and Novartis signed a new 5-year partnership to deliver treatment and support services for chronic myeloid leukemia, metastatic breast cancer, PNH, and rare cancers across more than 80 low- and middle-income countries.PR NewswireThe Max Foundation and International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Partner to Enhance the Care of CLL in Low- and Middle-Income CountriesThe Max Foundation and the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) announced a partnership to enhance care for chronic lymphocytic leukemia patients in low- and middle-income countries. This collaboration involves iwCLL providing training and programmatic guidance to support an access program for BeiGene's innovative CLL therapy, BRUKINSA, across 29 LMICs over the next three years. The initiative aims to build capacity within healthcare institutions and improve health equity by expanding access to critical treatments.PR NewswireFierce names Pat Garcia-Gonzalez, Founder and CEO of The Max Foundation as one of its Fierce 50 Honorees of 2023 in the Health Equity CategoryThe Max Foundation announced that its Co-Founder and CEO, Pat Garcia-Gonzalez, was named a Health Equity Honoree in the 2023 Fierce 50 list by Fierce Healthcare and Fierce Life Sciences. The organization delivers over 10 million doses of cancer treatment annually to patients in 77 low- and middle-income countries through partnerships with physicians, hospitals, and NGOs.NovartisPartnering for improved cancer care around the globeNovartis partnered with the American Society for Clinical Pathology and the American Cancer Society in 2017 to improve cancer care across Africa, including Ethiopia, Rwanda, Tanzania, and Uganda, where approximately 650,000 people develop cancer annually and 510,000 die from lack of treatment access. The programs, funded by Novartis, include building healthcare capacity for immunohistochemistry analysis in six hospital laboratories and training healthcare professionals in biopsy transportation and chemotherapy administration. Novartis also collaborates with The Max Foundation on CMLPath to Care, an access-to-treatment program operating in nearly 70 countries that provides treatment and support to chronic myeloid leukemia patients at no cost.